[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-365828-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-365828-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","plasma-and-urine-circulating-tumor-dna-methylation-profiles-for-non-invasive-pancreatic-ductal-adenocarcinoma-detection-significant-findings-in-plasma-only","Plasma and Urine Circulating Tumor DNA Methylation Profiles for Non-Invasive Pancreatic Ductal Adenocarcinoma Detection - Significant Findings in Plasma Only","","Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy with limited treatment options, and early detection remains challenging due to the lack of reliable non-invasive biomarkers. This study investigated plasma and urine circulating tumor deoxyribonucleic acid (ctDNA) methylation profiles as potential biomarkers for PDAC detection. A total of 35 patients with PDAC and 10 non-cancerous controls were enrolled, and whole-genome bisulfite sequencing was performed on ctDNA extracted from both plasma and urine samples. Plasma ctDNA methylation profiles effectively distinguished cancerous from non-cancerous samples, particularly through differential methylation in intergenic regions, and hierarchical clustering grouped patients accurately. However, urine ctDNA showed no significant methylation differences, suggesting plasma-derived methylation is more informative than urine for non-invasive PDAC detection.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/plasma-and-urine-circulating-tumor-dna-methylation-profiles-for-non-invasive-pancreatic-ductal-adenocarcinoma-detection-significant-findings-in-plasma-only/365828/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/plasma-and-urine-circulating-tumor-dna-methylation-profiles-for-non-invasive-pancreatic-ductal-adenocarcinoma-detection-significant-findings-in-plasma-only/365828.png","ImageObject",300,407,{"name":42,"@type":43},"Quinn Holloway","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-19","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the study’s main goal for PDAC detection?","Question",{"text":63,"@type":64},"To evaluate whether plasma and urine ctDNA DNA methylation profiles can serve as non-invasive biomarkers for detecting pancreatic ductal adenocarcinoma.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were methylation profiles measured in the study?",{"text":68,"@type":64},"Whole-genome bisulfite sequencing was performed on ctDNA extracted from both plasma and urine samples.",{"name":70,"@type":61,"acceptedAnswer":71},"What did the study find about plasma versus urine biomarkers?",{"text":72,"@type":64},"Plasma ctDNA methylation profiles significantly distinguished PDAC from non-cancerous controls and enabled accurate patient grouping, while urine ctDNA showed no significant methylation differences.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},365828,1790212314,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":113,"preview_page_count":33,"preview_urls":146},2336474466712,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Article  \nPlasma and Urine Circulating Tumor DNA Methylation Profiles for Non-Invasive Pancreatic Ductal Adenocarcinoma Detection: Significant Findings in Plasma Only  \nTomoaki Ito 1,2, *, Takumi Iwasawa 2,3, Shunsuke Sakuraba 1 and Kenichiro Tanaka 1  \nAcademic Editor: Donatella Delle Cave  \nReceived: 14 April 2025  \nRevised: 15 May 2025  \nAccepted: 19 May 2025  \nPublished: 22 May 2025  \nCitation: Ito, T.; Iwasawa, T.; Sakuraba, S.; Tanaka, K. Plasma and Urine Circulating Tumor DNA Methylation Profiles for Non-Invasive Pancreatic DuctalAdenocarcinoma Detection: Significant Findings in Plasma Only. Int. J. Mol. Sci. 2025, 26, 4972. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)ijms26114972  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Department of Surgery, Juntendo University Shizuoka Hospital, Juntendo University School of Medicine, Shizuoka 410-2295, Japan; [sswatana@juntendo.ac.jp](sswatana@juntendo.ac.jp) (S.S.); [kn-tanaka@juntendo.ac.jp](kn-tanaka@juntendo.ac.jp) (K.T.)  \n2 Shizuoka Medical Research Center for Disaster, Juntendo University, Shizuoka 410-2295, Japan; [iwasawa@toyo.jp](iwasawa@toyo.jp)  \n3 Institute of Life Innovation Studies, Toyo University, Tokyo 115-8650, Japan  \n* Correspondence: [tomo-ito@juntendo.ac.jp](tomo-ito@juntendo.ac.jp); Tel.: +81-55-948-3111  \nAbstract: Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy with limited treatment options, and early detection remains challenging due to the lack of reliable non-invasive biomarkers. This study investigated plasma and urine circulating tumor deoxyribonucleic acid (ctDNA) methylation profiles as potential biomarkers for PDAC detection. A total of 35 patients with PDAC and 10 non-cancerous controls were enrolled, and whole-genome bisulfite sequencing was performed on ctDNA extracted from both plasma and urine samples. Plasma ctDNA methylation profiles effectively distinguished cancerous from non-cancerous samples, particularly through differential methylation in intergenic regions. Hierarchical clustering further enabled the accurate grouping of patients with PDAC. However, urine ctDNA did not show significant methylation differences. These findings suggest that plasma ctDNA methylation holds promise as a non-invasive biomarker for PDAC detection, whereas urine ctDNA appears less informative. Future research should validate these findings in larger cohorts and investigate machine learning approaches to improve diagnostic performance, ultimately facilitating earlier detection and improved patient outcomes.  \nKeywords: pancreatic ductal adenocarcinoma; circulating tumor DNA (ctDNA); DNA methylation; liquid biopsy; whole-genome bisulfite sequencing (WGBS)  \n1. Introduction  \nPancreatic ductal adenocarcinoma (PDAC) remains one of the most aggressive malignancies, characterized by a dismal prognosis and limited treatment options. Current diagnostic methods for PDAC predominantly rely on invasive procedures such as endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) and endoscopic retrograde cholangiopancreatography (ERCP) . Although these techniques are instrumental, false-negative results and potential complications are frequently associated with their use, emphasizing the pressing need for more reliable and less invasive diagnostic approaches [1] .  \nThe quest for effective blood-based biomarkers has led to the clinical adoption of carbohydrate antigen 19-9 (CA19-9) . However, the ability of CA19-9 to detect early-stage PDAC remains limited due to its elevation in non-malignant conditions and pancreaticobiliary diseases, underscoring the necessity for more specific markers [2] . At the genetic level, PDAC","cbCaiuUc3XRqTJGy","https://ap.wps.com/l/cbCaiuUc3XRqTJGy","pdf",1052388,12,"English","# Abstract\n# Introduction\n## Need for non-invasive biomarkers in PDAC\n## Limits of current diagnostic approaches such as CA19-9\n## Role of ctDNA and DNA methylation\n## Plasma versus urine liquid biopsy rationale\n# Methods and study design\n# Results\n## Plasma ctDNA methylation distinguishes PDAC\n## Urine ctDNA methylation lacks significant differences\n# Discussion and implications\n# Future work","[{\"question\":\"What was the study’s main goal for PDAC detection?\",\"answer\":\"To evaluate whether plasma and urine ctDNA DNA methylation profiles can serve as non-invasive biomarkers for detecting pancreatic ductal adenocarcinoma.\"},{\"question\":\"How were methylation profiles measured in the study?\",\"answer\":\"Whole-genome bisulfite sequencing was performed on ctDNA extracted from both plasma and urine samples.\"},{\"question\":\"What did the study find about plasma versus urine biomarkers?\",\"answer\":\"Plasma ctDNA methylation profiles significantly distinguished PDAC from non-cancerous controls and enabled accurate patient grouping, while urine ctDNA showed no significant methylation differences.\"}]","Plasma and Urine Circulating Tumor DNA Methylation Profiles for Non-Invasive Pancreatic Ductal Adenocarcinoma Detection - Significant Findings in Plasma Only | PDF",1790162549,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aaf2378219067c48e3884b12f51d90be.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/71f71cd768057119518f825d3e3f354e.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2d7dc0616548cec3f1cfc37a1a4541a9.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/668221b40f021defab32d60223f692b7.webp",980,1385]